Intron 2 Splice Mutation at CYP21 Gene in Patients with Congenital Adrenal Hyperplasia in the Republic of Macedonia

Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003; 349(8): 776-788.10.1056/NEJMra02156112930931Search in Google Scholar

New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Storner E, Levy DJ, Pang S, Levine LS. Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data. J Clin Endocrinol Metab 1983; 57(2): 320-326.10.1210/jcem-57-2-3206306039Search in Google Scholar

Miller WL, Morel Y. The molecular genetics of 21-hydroxylase deficiency. Annu Rev Genet 1989; 23:371-393.10.1146/annurev.ge.23.120189.0021032694937Search in Google Scholar

Speiser PW, New MI, While PC. Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14, DR1. N Engl J Med 1988; 319(1): 19-23.10.1056/NEJM1988070731901043260007Search in Google Scholar

Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A. New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 37(4): 650-667.Search in Google Scholar

White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrinol Rev 2000; 21(3): 245-291.Search in Google Scholar

Baumgartner-Parzer SM, Nowotny P, Heinze G, Waldhäusl W, Vierhapper H. Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a Middle European population. J Clin Endocrinol Metab 2005; 90(2): 775-778.10.1210/jc.2004-172815572419Search in Google Scholar

Strachan T. Molecular patology of 21-hydroxylase deficiency. J Inher Metab Dis 1994; 17(4): 430-441.10.1007/BF007113587967493Search in Google Scholar

Fitness J, Dixit N, Webster D, Torresani T, Pergolizzi R, Speiser PW, Day DJ. Genotyping og CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1999; 84(3): 960-966.Search in Google Scholar

White PC, Tusie-Luna MT, New MI, Speiser PW. Mutations in steroid 21-hydroxylase (CYP21). Hum Mutat 1994; 3(4): 373-378.10.1002/humu.13800304088081391Search in Google Scholar

Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci USA 1986; 83(9): 2841-2845.10.1073/pnas.83.9.28413234023486422Search in Google Scholar

Tusié-Luna MT, White PC. Gene conversion and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci USA 1995; 92(23): 10796-10800.10.1073/pnas.92.23.10796406997479886Search in Google Scholar

White PC, New MI, Dupont B. Structure of the human steroid 21-hydroxylase gene. Proc Natl Acad Sci USA 1986; 83(14): 5111-5115.10.1073/pnas.83.14.51113239003487786Search in Google Scholar

Jaaskelainen J, Levo A, Voutilainen R, Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in well defined population. J Clin Endocrinol Metab 1997; 82(10): 3293-3297.10.1210/jc.82.10.3293Search in Google Scholar

Krone N, Braun A, Rosher AA, Knorr D, Schwarz HP. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 2000; 85(3): 1059-1065.10.1210/jcem.85.3.6441Search in Google Scholar

Rosha RO, Billerbeck AEC, Pinto EM, Melo KFS, Lin CJ, Longui CA, Mendoca BB, Bachega TASS. The degree of external genitalia virilization in girls with 21-hydroxylase deficiency appears to be influenced by the CAG repeats in the androghen receptor gene. Clin Endocrinol 2008; 68(2): 226-232.Search in Google Scholar

Fardella CE, Poggi H, Pineda P, Soto J, Torrealba I, Cattani A, Oestreicher E, Foradori A. Salt-wasting congenital adrenal hyperplasia: detection of mutations in CYP21B gene in a Chilean population. J Clinic Endocrinol Metab 1998; 83 (9): 3357-3360.10.1210/jc.83.9.3357Search in Google Scholar

Mornet E, Crété P, Kuttenn F, Raux-Demay MCh, Boué J, White PC, Boué A. Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency. Am J Hum Genet 1991; 48(1): 79-88.Search in Google Scholar

Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, Chalder SM, Bozucka-Mankiewicz M, Hauffe BP, Malunowicz EM, Stewart PM, Shackleton CHL. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 2004; 363(9427): 2128-2135.10.1016/S0140-6736(04)16503-3Search in Google Scholar

Efremov GD, Dimovski AJ, Plaseska-Karanfilska D, Simjanovska L, Sukarova E, Koceva S. Laboratory Manual, 3rd ed. Nucleic Acid Based Methods in Human and Veterinerary Medicine. ICGEB Affiliated Center. Skopje, Republic of Macedonia, 1999.Search in Google Scholar

Lee HH, Chao HT, Ng HT, Choo KB. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia. J Med Genet 1996; 33(5): 371-375.10.1136/jmg.33.5.37110506048733045Search in Google Scholar

Wedell A. Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implication for diagnosis, prognosis ant treatment. Acta Pediatr 1998; 87(2): 159-164.10.1111/j.1651-2227.1998.tb00968.xSearch in Google Scholar

Wedell A, Thilen A, Ritzen EM, Stengler B, Luthman H. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestations. J Clin Endocrinol Metab 1994; 78(5): 1145-1152.10.1097/00006254-199410000-00020Search in Google Scholar

Ramazani A, Kahrizi K, Razaghiazar M, Mahdieh N, Koppens P. The frequency of eight common point mutations in CYP21 gene in Iranian patients with congenital adrenal hyperplasia. Iran Biomed J 2008; 12(1): 49-53.Search in Google Scholar

Dolžan V, Sólyom J, Fekete G, Kovács J, Rakosnikova V, Voltava F, Lebl J, Pribilincova Z, Baumgartner-Parzer SM, Riedl S, Waldhauser F, Frish H, Stopar-Obreza M, Kržišnik C. Battelino T. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in the Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol 2005; 153(1): 99-106.10.1530/eje.1.0194415994751Search in Google Scholar

Witchel SF, Bhamidipati DK, Hoffman EP, Cohen JB. Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1996; 81(11): 4081-4088.Search in Google Scholar

Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna M-T. Lesser M, New MI, White PC. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 1992; 90(2): 584-595.10.1172/JCI1158974431371644925Search in Google Scholar

Higashi Y, Tanae A, Inoue H, Hiromasa T, Fujii-Kuriyama Y. Aberrant splicing and missence mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: Possible gene conversion products. Proc Natl Acad Sci USA 1988; 85(20): 7486-7490.10.1073/pnas.85.20.74862822162845408Search in Google Scholar

Day DJ, Speiser PhW, Schulze E, Bettendorf M, Fitness J, Barany F, White PC. Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Molec Genet 1996; 5(12): 2039-2048.10.1093/hmg/5.12.2039Search in Google Scholar

Dolžan V, Stopar-Obreza M, Žerjav-Tanšek M, Breskvar K, Kržišnik C, Battelino T. Mutational spectrum of congenital adrenal hyperplasia in Slovenian patients: a novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease. Eur J Endocrinol 2003; 149(2): 137-144.10.1530/eje.0.1490137Search in Google Scholar

Miller WL. Congenital lipoid adrenal hyperplasia: the human gene knockout for the steroidogenic acute regulatory protein. J Molec Endocrinol 1997; 19(3): 227-240.10.1677/jme.0.0190227Search in Google Scholar

Rice DA, Kronenberg MS, Mouw AR, Aitken LD, Franklin A, Schimmer BP, Parker KL. Multiple regulatory elements determine adrenocortical expression of steroid 21-hydroxylase. J Biol Chem 1990; 265(14): 8052-8058.10.1016/S0021-9258(19)39037-4Search in Google Scholar

Donohoue PA, Collins MM. The human complement C4B/steroid 21-hydroxylase (CYP21) and complement C4A/21-hydroxylase pseudogene (CYP21P) intergenic sequences: comparasion and identification of possible regulatory elements. Biochem Biophys Res Commun 1992; 186(1): 256-262.10.1016/S0006-291X(05)80801-0Search in Google Scholar

Gomes LG, Huang N, Agrawal V, Mendonca BB, Bachega TASS, Miller WL. The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency. J Clin Endocrinol Metab 2008; 93(7): 2913-2916.10.1210/jc.2008-0304245304818397975Search in Google Scholar

Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-hydroxylase deficiency: Genotype may not predict phenotype. J Clin Endocrinol Metab 1995; 80(8): 2322-2329.Search in Google Scholar